These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 15187486
1. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers]. Kishimoto N, Ohnishi H, Fujita J, Kamei T, Tada S, Ueda N. Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486 [Abstract] [Full Text] [Related]
2. [beta 2-adrenoceptor polymorphism and effect of inhaled beta 2-stimulant (procaterol) on airway resistance measured by body plethysmography in healthy volunteers]. Kobayashi M, Kishimoto N, Ohnishi H, Tada S, Ueda N, Kamei T, Fujita J, Taguchi H. Nihon Kokyuki Gakkai Zasshi; 2002 Aug; 40(8):637-43. PubMed ID: 12428391 [Abstract] [Full Text] [Related]
3. [Beta 2-adrenoceptor polymorphism and effects of inhaled beta 2-stimulant (procaterol) and an anti-cholinergic drug (oxitropium) on the airway resistance]. Yamasaki Y, Kishimoto N, Ohnishi H, Fujita J, Kobayashi M, Kamei T, Tada S, Ueda N. Nihon Kokyuki Gakkai Zasshi; 2004 Mar; 42(3):239-46. PubMed ID: 15069780 [Abstract] [Full Text] [Related]
4. Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol. Dottorini ML, Tantucci C, Peccini F, Grassi V, Sorbini CA. Int J Clin Pharmacol Ther; 1996 Oct; 34(10):438-43. PubMed ID: 8897082 [Abstract] [Full Text] [Related]
5. Dose-related protection against histamine-induced bronchoconstriction by inhaled salmeterol. Maconochie JG, Denyer LH, Hassani H. Int J Clin Pharmacol Ther; 1994 Jul; 32(7):329-34. PubMed ID: 7952793 [Abstract] [Full Text] [Related]
6. Duration of oral procaterol protection from methacholine-induced bronchial obstruction. De Candussio G, Franchi D, Manini G, Arossa W, Castello D. Int J Clin Pharmacol Res; 1986 Jul; 6(5):403-7. PubMed ID: 2877955 [Abstract] [Full Text] [Related]
7. Computational fluid dynamics can detect changes in airway resistance in asthmatics after acute bronchodilation. De Backer JW, Vos WG, Devolder A, Verhulst SL, Germonpré P, Wuyts FL, Parizel PM, De Backer W. J Biomech; 2008 Jul; 41(1):106-13. PubMed ID: 17698073 [Abstract] [Full Text] [Related]
8. Bronchodilating effect and anabolic effect of inhaled procaterol. Ikezono K, Maeda T, Kamata M, Mori T, Yabuuchi Y. Int J Sports Med; 2008 Nov; 29(11):888-94. PubMed ID: 18461498 [Abstract] [Full Text] [Related]
9. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM. Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [Abstract] [Full Text] [Related]
10. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler. Kobayashi Y, Yasuba H, Kudou M, Kita H. J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319 [Abstract] [Full Text] [Related]
11. [The effect of salmeterol on the activity of neutrophil chemotactic factor in patients with asthma]. Kong L, Li Z, Yu R. Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr; 19(2):88-90. PubMed ID: 9388846 [Abstract] [Full Text] [Related]
12. [Therapy with nebulized beta2 agonists (procaterol) in asthmatic children: pulmonary function and plasma levels after inhalation]. Kishida M, Nakazono H, Kuroiwa R, Dokai H, Nakazato J, Nakamura H, Suzuki I, Shinomiya N. Arerugi; 2007 Nov; 56(11):1372-7. PubMed ID: 18059150 [Abstract] [Full Text] [Related]
13. Effect of procaterol, a beta(2) selective adrenergic receptor agonist, on airway inflammation and hyperresponsiveness. Tashimo H, Yamashita N, Ishida H, Nagase H, Adachi T, Nakano J, Yamamura K, Yano T, Yoshihara H, Ohta K. Allergol Int; 2007 Sep; 56(3):241-7. PubMed ID: 17582211 [Abstract] [Full Text] [Related]
14. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. Rowe BH, Wong E, Blitz S, Diner B, Mackey D, Ross S, Senthilselvan A. Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245 [Abstract] [Full Text] [Related]
15. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers. Maris NA, de Vos AF, Bresser P, van der Zee JS, Jansen HM, Levi M, van der Poll T. Crit Care Med; 2007 Jan; 35(1):57-63. PubMed ID: 17080003 [Abstract] [Full Text] [Related]
16. Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD. Andò F, Ruggeri P, Girbino G, Cazzola M. Respir Med; 2008 Jun; 102(6):815-8. PubMed ID: 18343646 [Abstract] [Full Text] [Related]
17. Effect of procaterol on arterial blood gas in asthmatic children. Obata T, Masaki T, Ilkura Y. Ann Allergy; 1990 Nov; 65(5):389-92. PubMed ID: 1978769 [Abstract] [Full Text] [Related]
18. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes. van Baak MA, de Hon OM, Hartgens F, Kuipers H. Int J Sports Med; 2004 Oct; 25(7):533-8. PubMed ID: 15459835 [Abstract] [Full Text] [Related]
19. Increased perception of dyspnea by inhalation of short acting beta2 agonist in patients with asthma of varying severity. Jang AS, Choi IS. Ann Allergy Asthma Immunol; 2000 Jan; 84(1):79-83. PubMed ID: 10674569 [Abstract] [Full Text] [Related]
20. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease. Vestbo J, Pauwels R, Anderson JA, Jones P, Calverley P, TRISTSAN study group. Thorax; 2005 Apr; 60(4):301-4. PubMed ID: 15790985 [Abstract] [Full Text] [Related] Page: [Next] [New Search]